The African Vaccine Regulatory Forum (AVAREF): A platform for collaboration in a public health emergency. (WHO Drug Information Vol. 29, No. 2, 2015)
(2015; 6 pages)


The Ebola virus disease outbreak in West Africa has been followed by a global multi-stakeholder response, led by WHO, to make medical products available to treat and prevent the disease. The swift pace of product development has challenged regulatory systems globally, and especially those of resource-constrained sub-Saharan African countries.

To address the challenge of authorizing clinical trials of Ebola candidate vaccines with limited available data, the WHO African Vaccine Regulatory Forum (AVAREF) was used as a collaboration platform enabling regulators, ethics committees and sponsors to reach consensus on key ethical and regulatory questions. Given AVAREF’s crucial role in speeding up product development through coordinated regulatory efforts to combat Ebola it is essential that necessary resources are allocated to further strengthen its capacity.

Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019